InvestorQ : Do you suggest buying into Aurobindo Pharma after its latest quarter results?
Katherine Gonsalves made post

Do you suggest buying into Aurobindo Pharma after its latest quarter results?

Answer
user profile image
Rutuja Nigam answered.
1 month ago


Aurobindo Pharma reported 22.81% rise in net profits at Rs.781 crore for Jun-20 quarter. For the Jun20 quarter, the total sales revenues were up 10% at Rs.5943 crore. Aurobindo saw good traction in its US formulations business which grew by 15%

US business accounts for 53% of Aurobindo revenues. Aurobindo Pharma has been one of the best pharma performers in the stock market since March, when the rally took off in a big way. It is now among the better bets in the pharma space and traders can still look at upsides although investors may wait for lower levels.